跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
pitavastatin + ezetimibe
首页
药物
pitavastatin + ezetimibe
pitavastatin + ezetimibe
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for treating hyperlipidemia
US 2006046996 A1
申请人: NISSAN CHEMICAL IND LTD
优先权: 2004
US
3 件公开
Solid oral pharmaceutical composition
CN 119925367 A
申请人: ORIENT PHARMA CO LTD
优先权: 2020
CN
2 件公开
US 11833133 B2
申请人: ORIENT PHARMA CO LTD
优先权: 2021
US
Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
CN 102451161 A
申请人: LIYAN WANG
优先权: 2010
CN
Pitavastatin calcium tablet and preparation method thereof
CN 111743869 A
申请人: NANJING GRITPHARMA CO LTD
优先权: 2019
CN
Ezetimibe and pitavastatin calcium compound double-layer tablet
CN 112999178 A
申请人: LEPU PHARMACEUTICAL TECH CO LTD
优先权: 2021
CN
SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING EZETIMIBE AND PITAVASTATIN
EP 4566591 B1
申请人: KRKA D D NOVO MESTO
优先权: 2023
EP
ORAL PHARMACEUTICAL COMPOSITION OF PITAVASTATIN AND EZETIMIBE, METHOD AND USES THEREOF
WO 2025186786 A8
申请人: TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA
优先权: 2024
WO
ORAL PHARMACEUTICAL COMPOSITION OF PITAVASTATIN, METHOD AND USES THEREOF
WO 2025186785 A8
申请人: TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA
优先权: 2024
WO
药物
反馈